Health
New combination therapy may help fight antimicrobial resistance – News-Medical.Net
An inexpensive, FDA-approved drug — cholestyramine — taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according…
An inexpensive, FDA-approved drug — cholestyramine — taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. The team’s findings appear today (Dec. 1) in the journal eLife.
“Antimicrobial resistance is a serious problem that has led to people dying from common bacterial infections,” said Andrew Read, Evan Pugh Professor of Biology and Entomology and director of the…
Continue Reading
